Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing dornase alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Dornase alfa adverse reaction |
Causative agent (attribute) |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Allergy to dornase alfa (finding) |
Causative agent (attribute) |
False |
Dornase alfa (substance) |
Inferred relationship |
Some |
|
Dornase alfa 2500units(2.5mg) nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dornase alfa (substance) |
Inferred relationship |
Some |
|
Allergy to dornase alfa (finding) |
Causative agent (attribute) |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing only dornase alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing dornase alfa in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Dornase alfa only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Dornase alfa 1 mg/mL solution for nebuliser |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |
Dornase alfa 1 mg/mL solution for nebuliser |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dornase alfa (substance) |
Inferred relationship |
Some |
1 |